Joshua (Josh) Resnick, MD

Josh Resnick is a Partner at RA Capital Management, where his official profile says he leads early-stage private investments and oversees the creation of new companies developing drugs, medical devices, diagnostics, and research tools. He has more than 15 years of experience across investing, company formation, company leadership, and drug development stages from discovery through commercialization. Before RA Capital, he was co-lead of SV Health Investors’ US Biotech practice, President and Managing Partner at MRL Ventures Fund, a Venture Partner at Atlas Venture, and a Partner at Prism Venture Partners. He is also listed as a Harvard Medical School faculty member and an attending physician in Emergency Medicine at Massachusetts General Hospital. He holds a BA in Chemistry from Williams College, an MD from the University of Pennsylvania School of Medicine, and an MBA from Wharton.